{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:06:07Z","timestamp":1784099167005,"version":"3.55.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>SARS-CoV-2 infection not only leads to severe respiratory diseases but also has a significant impact on the cardiovascular system, inducing acute cardiac injury and various long-term cardiovascular complications. Non-coding RNAs (ncRNAs), as key molecules in gene expression regulation, exhibit important regulatory roles in viral infections and cardiovascular pathological processes. Current research indicates that ncRNAs such as miRNA, lncRNA, and circRNA participate in the occurrence and development of cardiac injury related to SARS-CoV-2 infection by regulating apoptosis, metabolic reprogramming, and cell communication. However, there are still many challenges and unresolved mysteries regarding their specific regulatory networks and clinical applications. This review systematically summarizes the expression changes and functional characteristics of ncRNAs in COVID-19-related cardiovascular diseases, focusing on their potential as biomarkers and therapeutic targets, and combining the latest multi-omics data and cutting-edge technologies to anticipate the development direction of precise interventions and personalized treatments.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1837477","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:42Z","timestamp":1784095902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The regulatory mechanisms and translational applications of non-coding RNA in SARS-CoV-2 infection-related cardiovascular pathology"],"prefix":"10.3389","volume":"13","author":[{"given":"Ziwei","family":"Cao","sequence":"first","affiliation":[{"name":"School of Medical Laboratory Science, Shandong Second Medical University","place":["Weifang, Shandong, China"]},{"name":"Department of Basic Medical Sciences, The 960th Hospital of PLA","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, The 960th Hospital of PLA","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, The 960th Hospital of PLA","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/10815589221141841","article-title":"COVID-19\u2019s immuno-pathology and cardiovascular diseases","volume":"71","author":"Nasab","year":"2023","journal-title":"J Invest Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/diseases13080252","article-title":"Cardiovascular complications of COVID-19 disease: a narrative review","volume":"13","author":"Denegri","year":"2025","journal-title":"Diseases"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35658","article-title":"COVID-19 and cardiovascular diseases: a literature review from pathogenesis to diagnosis","author":"Naeem","year":"2023","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/cimb46030124","article-title":"COVID-19 associated cardiovascular disease\u2014risks, prevention and management: heart at risk due to COVID-19","volume":"46","author":"Kemerley","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/HCO.0000000000000958","article-title":"Coronavirus disease 2019 and the cardiologist","volume":"37","author":"Mohammad","year":"2022","journal-title":"Curr Opin Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2217\/fca-2021-0054","article-title":"COVID-19, cardiovascular diseases and cardiac troponins","volume":"18","author":"Kim","year":"2022","journal-title":"Future Cardiol"},{"key":"B7","first-page":"170","article-title":"Cardiovascular complications of COVID-19 severe acute respiratory syndrome","volume":"12","author":"Henning","year":"2022","journal-title":"Am J Cardiovasc Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9970","DOI":"10.12998\/wjcc.v10.i28.9970","article-title":"COVID-19 and the heart","volume":"10","author":"Xanthopoulos","year":"2022","journal-title":"World J Clin Cases"},{"key":"B9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10020-024-00855-2","article-title":"Pathogenic mechanisms of cardiovascular damage in COVID-19","volume":"30","author":"Shao","year":"2024","journal-title":"Mol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000533359","article-title":"Pathological interplay and clinical complications between COVID-19 and cardiovascular diseases: an overview in 2023","volume":"149","author":"Zhou","year":"2024","journal-title":"Cardiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s44161-022-00029-5","article-title":"The pathological maelstrom of COVID-19 and cardiovascular disease","volume":"1","author":"Giacca","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"B12","first-page":"54","article-title":"COVID-19 and cardiovascular disease: a comprehensive review","volume":"75","author":"Khalil","year":"2022","journal-title":"S D Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"00368504251322069","DOI":"10.1177\/00368504251322069","article-title":"COVID-19 beyond the lungs: unraveling its vascular impact and cardiovascular complications\u2014mechanisms and therapeutic implications","volume":"108","author":"Saha","year":"2025","journal-title":"Sci Prog"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.12809\/hkmj209217","article-title":"Cardiovascular complications of COVID-19","author":"Lo","year":"2022","journal-title":"Hong Kong Med J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100981","DOI":"10.1016\/j.cpcardiol.2021.100981","article-title":"The cardiac effects of COVID-19: review of articles","volume":"47","author":"Niazi","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.cpcardiol.2022.101250","article-title":"Molecular determinants, clinical manifestations and effects of immunization on cardiovascular health during COVID-19 pandemic era\u2014a review","volume":"48","author":"Chatterjee","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41392-023-01669-0","article-title":"Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance and therapeutic targets","volume":"8","author":"Liu","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ccep.2021.10.004","article-title":"COVID-19, acute myocardial injury, and infarction","volume":"14","author":"Del Prete","year":"2022","journal-title":"Card Electrophysiol Clin"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.14336\/AD.2023.0314","article-title":"COVID-19 and cardiovascular diseases: from cellular mechanisms to clinical manifestations","volume":"14","author":"Shu","year":"2023","journal-title":"Aging Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.69677","article-title":"Manifestations and mechanism of SARS-CoV2 mediated cardiac injury","volume":"18","author":"Xu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"901245","DOI":"10.3389\/fcvm.2022.901245","article-title":"Myocardial injury in COVID-19 and its implications in short- and long-term outcomes","volume":"9","author":"Izquierdo-Marquis\u00e1","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11886-023-01902-w","article-title":"COVID-19 and acute cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, and treatment","volume":"25","author":"Qiu","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/life12101605","article-title":"Endothelial dysfunction in COVID-19: potential mechanisms and possible therapeutic options","volume":"12","author":"Pelle","year":"2022","journal-title":"Life"},{"key":"B24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2174\/1389203724666230816092518","article-title":"ACE2 receptor: a potential pharmacological target in COVID-19","volume":"24","author":"Zhu","year":"2023","journal-title":"Curr Protein Pept Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"115370","DOI":"10.1016\/j.bcp.2022.115370","article-title":"Counter-regulatory renin-angiotensin system in hypertension: review and update in the era of COVID-19 pandemic","volume":"208","author":"Chen","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e15644","DOI":"10.1016\/j.heliyon.2023.e15644","article-title":"Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases","volume":"9","author":"Kunvariya","year":"2023","journal-title":"Heliyon"},{"key":"B27","doi-asserted-by":"publisher","first-page":"108255","DOI":"10.1016\/j.intimp.2021.108255","article-title":"The triumvirate of NF-\u03baB, inflammation and cytokine storm in COVID-19","volume":"101","author":"Attiq","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12985-022-01833-y","article-title":"Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update","volume":"19","author":"Yang","year":"2022","journal-title":"Virol J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2022.05.055","article-title":"SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress","volume":"362","author":"Tangos","year":"2022","journal-title":"Int J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"S655","DOI":"10.33549\/physiolres.935476","article-title":"Risk impact of SARS-CoV-2 coronavirus and spike protein on cardiac tissue: a comprehensive review","author":"\u0160er\u00fd","year":"2024","journal-title":"Physiol Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10741-021-10087-9","article-title":"COVID-19 and myocarditis: a systematic review and overview of current challenges","volume":"27","author":"Castiello","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/molecules27092903","article-title":"The pathophysiology of long COVID throughout the renin-angiotensin system","volume":"27","author":"Khazaal","year":"2022","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.15386\/mpr-2345","article-title":"Role of angiotensin converting enzyme-2 and its modulation in disease: exploring new frontiers","volume":"96","author":"Magazine","year":"2023","journal-title":"Med Pharm Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/molecules27072048","article-title":"Angiotensin II type I receptor (AT1R): the gate towards COVID-19-associated diseases","volume":"27","author":"El-Arif","year":"2022","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/cells11081316","article-title":"CVD and COVID-19: emerging roles of cardiac fibroblasts and myofibroblasts","volume":"11","author":"Katwa","year":"2022","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/CP9.0000000000000055","article-title":"Injury mechanism of COVID-19\u2013induced cardiac complications","volume":"8","author":"Leng","year":"2023","journal-title":"Cardiology Plus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.3390\/ijms24065374","article-title":"COVID-19-induced myocarditis: pathophysiological roles of ACE2 and toll-like receptors","volume":"24","author":"Pannucci","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.20517\/jca.2021.20","article-title":"COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance","author":"Robinson","year":"2022","journal-title":"J Cardiovasc Aging"},{"key":"B39","doi-asserted-by":"publisher","first-page":"H403","DOI":"10.1152\/ajpheart.00204.2022","article-title":"Mechanisms of COVID-19 pathogenesis in diabetes","volume":"323","author":"Aluganti Narasimhulu","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/03007995.2022.2078081","article-title":"COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication","volume":"38","author":"Abdel Moneim","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cytogfr.2021.11.001","article-title":"SARS-CoV-2 infection and oxidative stress: pathophysiological insight into thrombosis and therapeutic opportunities","volume":"63","author":"Alam","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3390\/biomedicines11082239","article-title":"Role of endothelium in cardiovascular sequelae of long COVID","volume":"11","author":"Santoro","year":"2023","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/ijms27010433","article-title":"Vascular complications of long COVID\u2014from endothelial dysfunction to systemic thrombosis: a systematic review","volume":"27","author":"Stojanovic","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541553","article-title":"Coronary implications of COVID-19","author":"Triantafyllis","year":"2024","journal-title":"Med Princ Pract"},{"key":"B45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.33963\/KP.a2022.0072","article-title":"Specific characteristics of STEMI in COVID-19 patients and their practical implications","volume":"80","author":"Gitto","year":"2022","journal-title":"Kardiol Pol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/v14020260","article-title":"Coronary stent thrombosis in COVID-19 patients: a systematic review of cases reported worldwide","volume":"14","author":"Skorupski","year":"2022","journal-title":"Viruses"},{"key":"B47","first-page":"43","article-title":"Neurological implications of cardiac compromise in COVID-19","volume":"13","author":"Finsterer","year":"2023","journal-title":"Am J Cardiovasc Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/jcdd9090292","article-title":"Effects of COVID-19 on arrhythmia","volume":"9","author":"Zhan","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.15586\/aei.v51i4.883","article-title":"Cardiac arrhythmia and immune response in COVID-19 patients","volume":"51","author":"Wang","year":"2023","journal-title":"Allergol Immunopathol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.7150\/ijms.94578","article-title":"The potential mechanisms of arrhythmia in coronavirus disease-2019","volume":"21","author":"Li","year":"2024","journal-title":"Int J Med Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/CP9.0000000000000046","article-title":"Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies","volume":"8","author":"Shu","year":"2023","journal-title":"Cardiology Plus"},{"key":"B52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.31083\/j.rcm2309298","article-title":"Coronavirus disease 2019 and takotsubo syndrome","volume":"23","author":"Zhou","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e160822207545","DOI":"10.2174\/1573403X18666220816143549","article-title":"Possible long-term cardiovascular effects of COVID-19","volume":"19","author":"Lugo","year":"2023","journal-title":"Curr Cardiol Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.jacep.2023.07.021","article-title":"SARS-CoV-2 infection precipitating VT storm in patients with cardiac sarcoidosis","volume":"9","author":"John","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/v15020389","article-title":"Cardiac arrhythmias in post-COVID syndrome: prevalence, pathology, diagnosis, and treatment","volume":"15","author":"Huseynov","year":"2023","journal-title":"Viruses"},{"key":"B56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/ars.2022.0126","article-title":"Long COVID-19 and the heart: is cardiac mitochondria the missing link?","volume":"38","author":"Chang","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"B57","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"Van Ham","year":"2022","journal-title":"JACC"},{"key":"B58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/life14020202","article-title":"Acute myocardial infarction during the COVID-19 pandemic: long-term outcomes and prognosis\u2014a systematic review","volume":"14","author":"Rus","year":"2024","journal-title":"Life"},{"key":"B59","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/diagnostics13030478","article-title":"Atherosclerosis, cardiovascular disorders and COVID-19: comorbid pathogenesis","volume":"13","author":"Makarova","year":"2023","journal-title":"Diagnostics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"859505","DOI":"10.3389\/fcvm.2022.859505","article-title":"Mechanisms of cardiovascular system injury induced by COVID-19 in elderly patients with cardiovascular history","volume":"9","author":"Yang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12265-022-10214-3","article-title":"MicroRNA-122-5p aggravates angiotensin II-mediated myocardial fibrosis and dysfunction in hypertensive rats by regulating the elabela\/apelin-APJ and ACE2-GDF15-porimin signaling","volume":"15","author":"Song","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.3390\/ijms22105263","article-title":"Circulating soluble ACE2 and upstream microRNA expressions in serum of type 2 diabetes mellitus patients","volume":"22","author":"Elemam","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2174\/0929867330666230515144133","article-title":"The impact of lncRNA-GAS5\/miRNA-200\/ACE2 molecular pathway on the severity of COVID-19","volume":"31","author":"Ayeldeen","year":"2024","journal-title":"Curr Med Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/epigenomes6020013","article-title":"Insights into cardiovascular defects and cardiac epigenome in the context of COVID-19","volume":"6","author":"Sarkar","year":"2022","journal-title":"Epigenomes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"105613","DOI":"10.1016\/j.meegid.2024.105613","article-title":"Illuminating the pathogenic role of SARS-CoV-2: insights into competing endogenous RNAs (ceRNAs) regulatory networks","volume":"122","author":"Aghajani Mir","year":"2024","journal-title":"Infect Genet Evol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ncrna.2024.08.007","article-title":"The relationship between microRNAs and COVID-19 complications","volume":"10","author":"Kebriaei","year":"2025","journal-title":"Noncoding RNA Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/ijms24032380","article-title":"Alterations in circulating miRNA levels after infection with SARS-CoV-2 could contribute to the development of cardiovascular diseases: what we know so far","volume":"24","author":"Pieri","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/genes13071146","article-title":"The effect of host miRNAs on prognosis in COVID-19: miRNA-155 may promote severity via targeting suppressor of cytokine signaling 1 (SOCS1) gene","volume":"13","author":"Gedikbasi","year":"2022","journal-title":"Genes (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/15476286.2022.2100629","article-title":"Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19","volume":"19","author":"Eyileten","year":"2022","journal-title":"RNA Biol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/diagnostics13010133","article-title":"miR-146a, miR-221, and miR-155 are involved in inflammatory immune response in severe COVID-19 patients","volume":"13","author":"Gayt\u00e1n-Pacheco","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1674049","DOI":"10.3389\/fimmu.2025.1674049","article-title":"Exploring ceRNA mechanisms in COVID-19 mRNA vaccine-induced myocarditis: implications for future vaccine design","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1149499","DOI":"10.3389\/fcell.2023.1149499","article-title":"Emerging role of long non-coding RNA MALAT1 related signaling pathways in the pathogenesis of lung disease","volume":"11","author":"Liu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"101562","DOI":"10.1016\/j.bbrep.2023.101562","article-title":"Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1","volume":"36","author":"Shaker","year":"2023","journal-title":"Biochem Biophys Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.omtn.2022.02.002","article-title":"Overexpression of cytosolic long noncoding RNA cytb protects against pressure-overload-induced heart failure via sponging microRNA-103-3p","volume":"27","author":"Zhang","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"B75","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","article-title":"Structure and degradation of circular RNAs regulate PKR activation in innate immunity","volume":"177","author":"Liu","year":"2019","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/bib\/bbaa334","article-title":"Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2","volume":"22","author":"Cai","year":"2021","journal-title":"Brief Bioinform"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/s41401-025-01516-8","article-title":"CircSARS-CV2-N1368 from SARS-CoV-2 impairs endothelial cell function through the upregulation of ATF7 to activate TLR4\/NF-\u03baB\/ROS signaling","volume":"46","author":"Wen","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2762582","DOI":"10.1155\/2022\/2762582","article-title":"Hsa_circ_0000479\/hsa-miR-149-5p\/RIG-I, IL-6 axis: a potential novel pathway to regulate immune response against COVID-19","volume":"2022","author":"Firoozi","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/gtmb.2024.0337","article-title":"Immune regulatory circular RNAs, circRasGEF1B and circHIPK3, are upregulated in peripheral blood mononuclear cells of COVID-19 patients","volume":"28","author":"Mirzaei","year":"2024","journal-title":"Genet Test Mol Biomarkers"},{"key":"B81","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.1038\/s41598-021-86134-0","article-title":"A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood","volume":"11","author":"Wu","year":"2021","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.2147\/DDDT.S245199","article-title":"Silencing of circHIPK3 inhibits pressure overload-induced cardiac hypertrophy and dysfunction by sponging miR-185-3p","volume":"14","author":"Xu","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"105636","DOI":"10.1016\/j.antiviral.2023.105636","article-title":"SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor captopril","volume":"215","author":"Huang","year":"2023","journal-title":"Antiviral Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/15321819.2022.2035394","article-title":"Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients","volume":"43","author":"Pinacchio","year":"2022","journal-title":"J Immunoassay Immunochem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"111413","DOI":"10.1016\/j.mad.2020.111413","article-title":"Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients","volume":"193","author":"Sabbatinelli","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"B86","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1016\/j.celrep.2021.109839","article-title":"Role of miR-2392 in driving SARS-CoV-2 infection","volume":"37","author":"McDonald","year":"2021","journal-title":"Cell Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/bph.17392","article-title":"Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patients","volume":"182","author":"Di Pietro","year":"2025","journal-title":"Br J Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/cvr\/cvae138","article-title":"Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition","volume":"120","author":"Zhang","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12959-024-00649-w","article-title":"Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19","volume":"22","author":"Helin","year":"2024","journal-title":"Thromb J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e2403581121","DOI":"10.1073\/pnas.2403581121","article-title":"SARS-CoV-2 pathogenesis in an angiotensin II\u2013induced heart-on-a-chip disease model and extracellular vesicle screening","volume":"121","author":"Wu","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00018-021-04119-8","article-title":"Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells","volume":"79","author":"Barbagallo","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/genes17010034","article-title":"circRNA signatures distinguishing COVID-19 outcomes and acute respiratory distress syndrome: a longitudinal, two-timepoint, precision-weighted analysis of a public RNA-Seq cohort","volume":"17","author":"Habara","year":"2025","journal-title":"Genes (Basel)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0283589","DOI":"10.1371\/journal.pone.0283589","article-title":"Mapping CircRNA-miRNA-mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection","volume":"18","author":"Ayaz","year":"2023","journal-title":"PLoS One"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1113\/JP283200","article-title":"Extracellular vesicles and their non-coding RNA cargos: emerging players in cardiovascular disease","volume":"601","author":"Collado","year":"2023","journal-title":"J Physiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/biology12050745","article-title":"Exosomal non-coding RNA mediates macrophage polarization: roles in cardiovascular diseases","volume":"12","author":"Wang","year":"2023","journal-title":"Biology (Basel)"},{"key":"B96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.32607\/actanaturae.27610","article-title":"Identifying microRNA expression alterations in erythrocytes, lymphocytes, and monocytes during severe COVID-19","volume":"18","author":"Artamonov","year":"2026","journal-title":"Acta Nat"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/ijms27031334","article-title":"Extracellular vesicle-derived MicroRNAs\u2019 value in diagnosing and predicting clinical outcomes in patients with COVID-19 and bacterial sepsis","volume":"27","author":"Schiavello","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41423-021-00652-5","article-title":"Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6\/IL-6R-associated cytokine storms in COVID-19 patients","volume":"18","author":"Yang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/cvr\/cvab094","article-title":"Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST action CA17129","volume":"117","author":"Badimon","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cvr\/cvab338","article-title":"Association of cardiometabolic microRNAs with COVID-19 severity and mortality","volume":"118","author":"Gutmann","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12967-023-04497-6","article-title":"HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients","volume":"21","author":"Greco","year":"2023","journal-title":"J Transl Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12985-024-02408-9","article-title":"Long non-coding RNAs in biomarking COVID-19: a machine learning-based approach","volume":"21","author":"Heydari","year":"2024","journal-title":"Virol J"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e0261242","DOI":"10.1371\/journal.pone.0261242","article-title":"Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: an integrated single-cell analysis","volume":"17","author":"Huang","year":"2022","journal-title":"PLoS One"},{"key":"B104","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ncrna.2026.01.008","article-title":"CircRNA-regulated programmed cell death networks in cardiomyocytes: molecular crosstalk and therapeutic translation","volume":"18","author":"Jiang","year":"2026","journal-title":"Noncoding RNA Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"0038","DOI":"10.34133\/research.0038","article-title":"Circular RNAs in cardiovascular diseases: regulation and therapeutic applications","volume":"6","author":"Wang","year":"2023","journal-title":"Research"},{"key":"B106","doi-asserted-by":"publisher","first-page":"108201","DOI":"10.1016\/j.intimp.2021.108201","article-title":"In vitro induction of interleukin-8 by SARS-CoV-2 spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR","volume":"101","author":"Gasparello","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.ijbiomac.2022.09.105","article-title":"Non-coding RNA in SARS-CoV-2: progress toward therapeutic significance","volume":"222","author":"Shirvani","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"12502","DOI":"10.1093\/nar\/gkab1096","article-title":"Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs","volume":"49","author":"Pfafenrot","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"105370","DOI":"10.1016\/j.antiviral.2022.105370","article-title":"A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera","volume":"204","author":"Seephetdee","year":"2022","journal-title":"Antiviral Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/biomedicines13020485","article-title":"Genetic and epigenetic intersections in COVID-19-associated cardiovascular disease: emerging insights and future directions","volume":"13","author":"Sabit","year":"2025","journal-title":"Biomedicines"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur Heart J"},{"key":"B113","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/HCO.0000000000001210","article-title":"RNA Therapeutics in cardiovascular medicine","volume":"40","author":"Damase","year":"2025","journal-title":"Curr Opin Cardiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1228160","DOI":"10.3389\/fcvm.2023.1228160","article-title":"Harnessing the power of RNA therapeutics in treating ischemic heart failure: the TRAIN-HEART story","volume":"10","author":"Albert","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1002\/mco2.720","article-title":"Synthetic circRNA therapeutics: innovations, strategies, and future horizons","volume":"5","author":"Cai","year":"2024","journal-title":"MedComm"},{"key":"B116","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/life16020268","article-title":"Myocardial and vascular involvement in COVID-19 and post-vaccination states: understanding injury pathways and clinical implications","volume":"16","author":"Siliste","year":"2026","journal-title":"Life"},{"key":"B117","doi-asserted-by":"publisher","first-page":"108904","DOI":"10.1016\/j.pharmthera.2025.108904","article-title":"Unveiling the silent threat: cOVID-19 and myocardial injury","volume":"273","author":"Xu","year":"2025","journal-title":"Pharmacol Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"200576","DOI":"10.1016\/j.ijcrp.2026.200576","article-title":"Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era.","volume":"28","author":"Birla","year":"2026","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e0297664","DOI":"10.1371\/journal.pone.0297664","article-title":"Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage","volume":"19","author":"Chang","year":"2024","journal-title":"PLoS One"},{"key":"B120","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40292-025-00738-5","article-title":"Artificial intelligence in cardiovascular health: insights into post-COVID public health challenges","volume":"32","author":"Naushad","year":"2025","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/s41591-022-02000-0","article-title":"Long-term cardiac pathology in individuals with mild initial COVID-19 illness","volume":"28","author":"Puntmann","year":"2022","journal-title":"Nat Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jacbts.2021.10.011","article-title":"The pathogenesis and long-term consequences of COVID-19 cardiac injury","volume":"7","author":"Siripanthong","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66554","article-title":"The long-term cardiovascular impact of COVID-19: pathophysiology, clinical manifestations, and management","author":"Mukkawar","year":"2024","journal-title":"Cureus"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1837477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:44Z","timestamp":1784095904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1837477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":123,"alternative-id":["10.3389\/fcvm.2026.1837477"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1837477","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1837477"}}